Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -41.08%130.8M | -34.18%140.2M | 16.65%215.8M | 11.53%837.7M | 21.08%217.7M | 7.14%222M | 22.27%213M | -2.58%185M | -18.36%751.1M | -15.55%179.8M |
| Operating revenue | -40.97%130.4M | -34.26%138.9M | 17.99%213.8M | 12.93%829.9M | 22.39%216.5M | 8.39%220.9M | 24.51%211.3M | -1.79%181.2M | -18.86%734.9M | -15.52%176.9M |
| Cost of revenue | -37.54%61.4M | -28.75%63.7M | 5.17%85.4M | 140.21%775.4M | 528.41%506.5M | 15.65%98.3M | 17.94%89.4M | -0.25%81.2M | 558.78%322.8M | 133.82%80.6M |
| Gross profit | -43.90%69.4M | -38.11%76.5M | 25.63%130.4M | -85.45%62.3M | -391.13%-288.8M | 1.23%123.7M | 25.61%123.6M | -4.33%103.8M | -50.83%428.3M | -78.01%99.2M |
| Operating expense | -9.69%67.1M | -18.62%59M | 10.71%88.9M | 10.18%311.8M | 33.39%84.7M | -9.17%74.3M | 7.89%72.5M | 13.90%80.3M | 12.08%283M | -2.16%63.5M |
| Selling and administrative expenses | 1,916.67%12.1M | -17.24%4.8M | -41.38%8.5M | -18.47%28.7M | 212.00%7.8M | -96.94%600K | -4.92%5.8M | 107.14%14.5M | -24.30%35.2M | -37.50%2.5M |
| -General and administrative expense | 1,916.67%12.1M | -17.24%4.8M | -41.38%8.5M | -18.47%28.7M | 212.00%7.8M | -96.94%600K | -4.92%5.8M | 107.14%14.5M | -24.30%35.2M | -37.50%2.5M |
| Other operating expenses | -25.37%55M | -18.74%54.2M | 22.19%80.4M | 14.25%283.1M | 26.07%76.9M | 18.49%73.7M | 9.17%66.7M | 3.62%65.8M | 20.29%247.8M | 0.16%61M |
| Operating profit | -95.34%2.3M | -65.75%17.5M | 76.60%41.5M | -271.71%-249.5M | -1,146.22%-373.5M | 22.28%49.4M | 63.78%51.1M | -38.16%23.5M | -76.51%145.3M | -90.76%35.7M |
| Net non-operating interest income (expenses) | 50.49%-5.1M | 32.18%-5.9M | -5.19%-8.1M | -13.74%-35.6M | -25.35%-8.9M | -21.18%-10.3M | -3.57%-8.7M | -5.48%-7.7M | 8.21%-31.3M | 10.13%-7.1M |
| Non-operating interest expense | -51.55%4.7M | -34.57%5.3M | 8.45%7.7M | 14.83%33.3M | 29.23%8.4M | 22.78%9.7M | 3.85%8.1M | 4.41%7.1M | -8.23%29M | -13.33%6.5M |
| Total other finance cost | -33.33%400K | 0.00%600K | -33.33%400K | 0.00%2.3M | -16.67%500K | 0.00%600K | 0.00%600K | 20.00%600K | -8.00%2.3M | 50.00%600K |
| Other net income (expenses) | 455.56%20M | 25.00%8M | -3,350.00%-13M | -32.43%20M | -45.14%9.6M | 350.00%3.6M | 255.56%6.4M | -95.79%400K | 243.00%29.6M | 153.62%17.5M |
| Gain on sale of security | 76.47%3M | 5.97%7.1M | -1,036.36%-12.5M | -34.33%15.3M | -48.72%8M | 342.86%1.7M | 737.50%6.7M | -114.47%-1.1M | 197.08%23.3M | 218.37%15.6M |
| Special income (charges) | ---2.5M | -114.29%-3M | -2,200.00%-2.3M | -200.00%-1.5M | --0 | --0 | -1,300.00%-1.4M | ---100K | 72.22%-500K | --0 |
| -Less:Restructuring and mergern&acquisition | --1M | 107.14%2.9M | --2.3M | --1.4M | --0 | --0 | --1.4M | --0 | --0 | --0 |
| -Less:Other special charges | --1.5M | --100K | ---- | -80.00%100K | --0 | ---- | ---- | --100K | 162.50%500K | --0 |
| Other non-operating income (expenses) | 926.32%19.5M | 254.55%3.9M | 12.50%1.8M | -8.82%6.2M | -15.79%1.6M | 0.00%1.9M | 0.00%1.1M | -15.79%1.6M | 33.33%6.8M | -5.00%1.9M |
| Income before tax | -59.72%17.2M | -59.84%19.6M | 25.93%20.4M | -284.61%-265.1M | -908.68%-372.8M | 30.58%42.7M | 98.37%48.8M | -59.70%16.2M | -74.53%143.6M | -88.04%46.1M |
| Income tax | -95.79%400K | -63.25%4.3M | 16.28%5M | -275.56%-62.5M | -845.76%-88M | 20.25%9.5M | 88.71%11.7M | -55.67%4.3M | 114.45%35.6M | 104.79%11.8M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -49.40%16.8M | -58.76%15.3M | 29.41%15.4M | -287.59%-202.6M | -930.32%-284.8M | 33.87%33.2M | 101.63%37.1M | -60.98%11.9M | -86.67%108M | -94.57%34.3M |
| Net income continuous operations | -49.40%16.8M | -58.76%15.3M | 29.41%15.4M | -287.59%-202.6M | -930.32%-284.8M | 33.87%33.2M | 101.63%37.1M | -60.98%11.9M | -86.67%108M | -94.57%34.3M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -49.40%16.8M | -58.76%15.3M | 29.41%15.4M | -287.59%-202.6M | -930.32%-284.8M | 33.87%33.2M | 101.63%37.1M | -60.98%11.9M | -86.67%108M | -94.57%34.3M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -49.40%16.8M | -58.76%15.3M | 29.41%15.4M | -287.59%-202.6M | -930.32%-284.8M | 33.87%33.2M | 101.63%37.1M | -60.98%11.9M | -86.67%108M | -94.57%34.3M |
| Diluted earnings per share | -43.18%0.25 | -54.17%0.22 | 40.00%0.21 | -300.75%-2.67 | -990.48%-3.74 | 41.94%0.44 | 118.18%0.48 | -59.46%0.15 | -86.54%1.33 | -94.55%0.42 |
| Basic earnings per share | -42.86%0.24 | -54.35%0.21 | 33.33%0.2 | -308.59%-2.67 | -1,058.97%-3.74 | 40.00%0.42 | 109.09%0.46 | -58.33%0.15 | -86.67%1.28 | -94.79%0.39 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.